Group One Trading
CRDF icon

Group One Trading’s Cardiff Oncology CRDF Stock Holding History

Group One Trading’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$284K Buy
175,200
+9,600
+6% +$19.7K ﹤0.01% 3856
2025
Q4 		$465K Buy
165,600
+45,900
+38% +$107K ﹤0.01% 3599
2025
Q3 		$247K Buy
119,700
+106,300
+793% +$294K ﹤0.01% 4444
2025
Q2 		$42.2K Sell
13,400
-25,100
-65% -$76.6K ﹤0.01% 5718
2025
Q1 		$121K Sell
38,500
-56,400
-59% -$223K ﹤0.01% 4451
2024
Q4 		$412K Buy
94,900
+94,000
+10,444% +$294K ﹤0.01% 3333
2024
Q3 		$2.4K Sell
900
-3,500
-80% -$8.27K ﹤0.01% 6102
2024
Q2 		$9.77K Sell
4,400
-21,000
-83% -$79.1K ﹤0.01% 5660
2024
Q1 		$136K Buy
25,400
+2,900
+13% +$7.71K ﹤0.01% 3878
2023
Q4 		$33.3K Sell
22,500
-36,700
-62% -$44.4K ﹤0.01% 5359
2023
Q3 		$82.3K Buy
59,200
+58,500
+8,357% +$98.7K ﹤0.01% 4634
2023
Q2 		$1.03K Sell
700
-4,800
-87% -$7.74K ﹤0.01% 7252
2023
Q1 		$9.07K Buy
5,500
+5,100
+1,275% +$8.76K ﹤0.01% 5983
2022
Q4 		$560 Sell
400
-9,800
-96% -$14K ﹤0.01% 6929
2022
Q3 		$16K Sell
10,200
-2,300
-18% -$5.54K ﹤0.01% 6212
2022
Q2 		$28K Sell
12,500
-35,700
-74% -$59.8K ﹤0.01% 6027
2022
Q1 		$120K Buy
48,200
+39,100
+430% +$138K ﹤0.01% 5312
2021
Q4 		$55K Sell
9,100
-107,500
-92% -$641K ﹤0.01% 6251
2021
Q3 		$777K Buy
116,600
+71,200
+157% +$447K ﹤0.01% 3691
2021
Q2 		$302K Sell
45,400
-35,200
-44% -$299K ﹤0.01% 4777
2021
Q1 		$746K Buy
80,600
+56,400
+233% +$685K ﹤0.01% 3566
2020
Q4 		$435K Sell
24,200
-4,000
-14% -$70.3K ﹤0.01% 3390
2020
Q3 		$400K Buy
+28,200
New +$186K ﹤0.01% 3045

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Group One Trading's CRDF Position: Q1 2026 in Review

Group One Trading reduced its Cardiff Oncology (CRDF) stake by 40% in Q1 2026, selling an estimated $34.3K and leaving 25,175 shares worth $40.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5418.

Group One Trading first reported a position in CRDF in Q2 2021 and has held it in 18 quarters since. The position peaked at $482K in Q3 2021. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Group One Trading held 25,175 shares of Cardiff Oncology worth $40.8K as of Q1 2026.
  • Group One Trading sold 16,699 Cardiff Oncology shares in Q1 2026, an estimated $34.3K.
  • Cardiff Oncology made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5418 holding.
  • Group One Trading first reported a position in Cardiff Oncology in Q2 2021 and has held it in 18 quarters since.
  • Group One Trading's Cardiff Oncology position peaked at $482K in Q3 2021.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.